Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension

<div>Right ventricular remodeling in congenital heart disease and pulmonary hypertension. <i>β</i>MHC: <i>β</i>-myosin heavy chain; HIF1<i>α</i>: hypoxia inducible factor 1<i>α</i>; VEGF: vascular endothelial growth factor; SERCA2a: sarcoplasmic/endoplasmic reticulum Ca2+ ATPase 2a; IVS: interventricular septum; <i>α</i>MHC: <i>α</i>-myosin heavy chain; FAO: fatty acids oxidation; RV-PA coupling: right ventricular-pulmonary arterial coupling; PVR: pulmonary vascular resistances; RV: right ventricular; iPAH: idiopathic pulmonary arterial hypertension; CTEPH: chronic thromboembolic pulmonary hypertension.</div>

BioMed Research International

fig3

Figure 3

Figure 3: Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension 

Figure 3 | Current Knowledge and Recent Advances of Right Ventricular Molecular Biology and Metabolism from Congenital Heart Disease to Chronic Pulmonary Hypertension 